Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Enterostomy | Research

Long term persistence and risk factors for anorectal symptoms following low anterior resection for rectal cancer

Authors: E. Koifman, M. Armoni, Y. Gorelik, A. Harbi, Y. Streltsin, S. D. Duek, R. Brun, Y. Mazor

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Background

Rectal cancer is commonly treated by chemoradiation therapy, followed by the low anterior resection anal sphincter-preserving surgery, with a temporary protecting ileostomy. After reversal of the stoma a condition known as low anterior resection syndrome (LARS) can occur characterized by a combination of symptoms such as urgent bowel movements, lack of control over bowel movements, and difficulty fully emptying the bowels. These symptoms have a significant negative impact on the quality of life for individuals who have survived the cancer. Currently, there is limited available data regarding the presence, risk factors, and effects of treatment for these symptoms during long-term follow-up.

Aims

To evaluate long term outcomes of low anterior resection surgery and its correlation to baseline anorectal manometry (ARM) parameters and physiotherapy with anorectal biofeedback (BF) treatment.

Methods

One hundred fifteen patients (74 males, age 63 ± 11) who underwent low anterior resection surgery for rectal cancer were included in the study. Following surgery, patients were managed by surgical and oncologic team, with more symptomatic LARS patients referred for further evaluation and treatment by gastroenterologists. At follow up, patients were contacted and offered participation in a long term follow up by answering symptom severity and quality of life (QOL) questionnaires.

Results

80 (70%) patients agreed to participate in the long term follow up study (median 4 years from stoma reversal, range 1–8). Mean time from surgery to stoma closure was 6 ± 4 months. At long term follow up, mean LARS score was 30 (SD 11), with 55 (69%) patients classified as major LARS (score > 30). Presence of major LARS was associated with longer time from surgery to stoma reversal (6.8 vs. 4.8 months; p = 0.03) and with adjuvant chemotherapy (38% vs. 8%; p = 0.01). Patients initially referred for ARM and BF were more likely to suffer from major LARS at long term follow up (64% vs. 16%, p < 0.001). In the subgroup of patients who underwent perioperative ARM (n = 36), higher maximal squeeze pressure, higher maximal incremental squeeze pressure and higher rectal pressure on push were all associated with better long-term outcomes of QOL parameters (p < 0.05 for all). 21(54%) of patients referred to ARM were treated with BF, but long term outcomes for these patients were not different from those who did not perform BF.

Conclusions

A significant number of patients continue to experience severe symptoms and a decline in their quality of life even 4 years after undergoing low anterior resection surgery. Prolonged time until stoma reversal and adjuvant chemotherapy emerged as the primary risk factors for a negative prognosis. It is important to note that referring patients for anorectal physiology testing alone tended to predict poorer long-term outcomes, indicating the presence of selection bias. However, certain measurable manometric parameters could potentially aid in identifying patients who are at a higher risk of experiencing unfavorable functional outcomes. There is a critical need to enhance current treatment options for this patient group.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol. 2012;3(3):153–73.PubMedPubMedCentral Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol. 2012;3(3):153–73.PubMedPubMedCentral
2.
go back to reference Siegel RL, Miller KD, Goding SA. Colorectal cancer statistics. CA Cancer J Clin. 2020;70(3):145–64.CrossRefPubMed Siegel RL, Miller KD, Goding SA. Colorectal cancer statistics. CA Cancer J Clin. 2020;70(3):145–64.CrossRefPubMed
3.
go back to reference Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103.PubMedPubMedCentral Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103.PubMedPubMedCentral
4.
go back to reference Monson JRT, Weiser MR, Buie WD, Chang GJ, Rafferty JF. Practice parameters for the management of rectal cancer. Dis Colon Rectum. 2013;56:535–50.CrossRefPubMed Monson JRT, Weiser MR, Buie WD, Chang GJ, Rafferty JF. Practice parameters for the management of rectal cancer. Dis Colon Rectum. 2013;56:535–50.CrossRefPubMed
6.
go back to reference Kupsch J, Jackisch T, Matzel KE, Zimmer J, Schreiber A, Sims A, Witzigmann H, Stelzner S. Outcome of bowel function following anterior resection for rectal cancer – an analysis using the low anterior resection syndrome (LARS) score. Int J Color Dis. 2018;33:787–98.CrossRef Kupsch J, Jackisch T, Matzel KE, Zimmer J, Schreiber A, Sims A, Witzigmann H, Stelzner S. Outcome of bowel function following anterior resection for rectal cancer – an analysis using the low anterior resection syndrome (LARS) score. Int J Color Dis. 2018;33:787–98.CrossRef
7.
go back to reference Martellucci J. Low anterior resection syndrome: a treatment algorithm. Dis Colon Rectum. 2016;59:79–82.CrossRefPubMed Martellucci J. Low anterior resection syndrome: a treatment algorithm. Dis Colon Rectum. 2016;59:79–82.CrossRefPubMed
8.
go back to reference Ekkarat P, Boonpipattanapong T, Tantiphlachiva K, Sangkhathat S. Factors determining low anterior resection syndrome after rectal cancer resection: A study in Thai patients. Asian J Surg. 2016;39(4):225–31.CrossRefPubMed Ekkarat P, Boonpipattanapong T, Tantiphlachiva K, Sangkhathat S. Factors determining low anterior resection syndrome after rectal cancer resection: A study in Thai patients. Asian J Surg. 2016;39(4):225–31.CrossRefPubMed
9.
go back to reference Coco C, Valentini V, Manno A, Rizzo G, Gambacorta M, Mattana C, Picciocchi A. Functional results after radio-chemotherapy and total mesorectal excision for rectal cancer. Int J Colorectal Dis. 2007;22(8):903–10.CrossRefPubMed Coco C, Valentini V, Manno A, Rizzo G, Gambacorta M, Mattana C, Picciocchi A. Functional results after radio-chemotherapy and total mesorectal excision for rectal cancer. Int J Colorectal Dis. 2007;22(8):903–10.CrossRefPubMed
10.
go back to reference Emmertsen K, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255:922–8.CrossRefPubMed Emmertsen K, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255:922–8.CrossRefPubMed
11.
go back to reference Juul T, Ahlberg M, Biondo S, et al. Internal validation of the low anterior resection syndrome score. Ann Surg. 2014;259:728–34.CrossRefPubMed Juul T, Ahlberg M, Biondo S, et al. Internal validation of the low anterior resection syndrome score. Ann Surg. 2014;259:728–34.CrossRefPubMed
12.
go back to reference Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum. 1999;42:1525–32.CrossRefPubMed Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum. 1999;42:1525–32.CrossRefPubMed
13.
go back to reference Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRefPubMed Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRefPubMed
14.
go back to reference Rockwood TH, Church JM, Fleshman W, et al. Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9–16.CrossRefPubMed Rockwood TH, Church JM, Fleshman W, et al. Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9–16.CrossRefPubMed
15.
go back to reference Ziv Y, Zbar A, Bar-Shavit Y, Igov I. Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations. Tech Coloproctol. 2013;17(2):151–62.CrossRefPubMed Ziv Y, Zbar A, Bar-Shavit Y, Igov I. Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations. Tech Coloproctol. 2013;17(2):151–62.CrossRefPubMed
16.
go back to reference Bregendahl S, Emmertsen KJ, Lous J, Laurberg S. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Color Dis. 2013;15(9):1130–9.CrossRef Bregendahl S, Emmertsen KJ, Lous J, Laurberg S. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Color Dis. 2013;15(9):1130–9.CrossRef
17.
go back to reference Sturiale A, Martellucci J, Zurli L, Vaccaro C, Brusciano L, Limongelli P, Docimo L, Valeri A. Long-term functional follow-up after anterior rectal resection for cancer. Int J Color Dis. 2017;32:83–8.CrossRef Sturiale A, Martellucci J, Zurli L, Vaccaro C, Brusciano L, Limongelli P, Docimo L, Valeri A. Long-term functional follow-up after anterior rectal resection for cancer. Int J Color Dis. 2017;32:83–8.CrossRef
18.
go back to reference Rasmussen OO, Petersen IK, Christiansen J. Anorectal function following low anterior resection. Color Dis. 2003;5(3):258–61.CrossRef Rasmussen OO, Petersen IK, Christiansen J. Anorectal function following low anterior resection. Color Dis. 2003;5(3):258–61.CrossRef
19.
go back to reference Vogel I, Reeves N, Tanis PJ, Bemelman W, Torkington J, Hompes R, Cornish J. Impact of a defunctioning ileostomy and time to stoma closure on bowel function after low anterior resection for rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2021;25:751–60.CrossRefPubMedPubMedCentral Vogel I, Reeves N, Tanis PJ, Bemelman W, Torkington J, Hompes R, Cornish J. Impact of a defunctioning ileostomy and time to stoma closure on bowel function after low anterior resection for rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2021;25:751–60.CrossRefPubMedPubMedCentral
20.
go back to reference Matthiessen P, Hallböök O, Rutegård J, Simert G, Sjödahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007;246(2):207–14.CrossRefPubMedPubMedCentral Matthiessen P, Hallböök O, Rutegård J, Simert G, Sjödahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007;246(2):207–14.CrossRefPubMedPubMedCentral
21.
go back to reference Yin TC, Tsai HL, Yang PF, Su W, Ma C, Huang C, Huang M, Huang C, Wang J. Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer. World J Surg Oncol. 2017;15(1):80.CrossRefPubMedPubMedCentral Yin TC, Tsai HL, Yang PF, Su W, Ma C, Huang C, Huang M, Huang C, Wang J. Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer. World J Surg Oncol. 2017;15(1):80.CrossRefPubMedPubMedCentral
22.
go back to reference Ye L, Huang M, Huang Y, Yu K, Wang X. Risk factors for postoperative low anterior resection syndrome for colorectal cancer: a meta-analysis. Asian J Surg. 2022;45(1):39–50.CrossRefPubMed Ye L, Huang M, Huang Y, Yu K, Wang X. Risk factors for postoperative low anterior resection syndrome for colorectal cancer: a meta-analysis. Asian J Surg. 2022;45(1):39–50.CrossRefPubMed
23.
go back to reference Croese A, Lonie J, Trollope A, Vangaveti VN, Ho YH. A meta-analysis of the prevalence of low anterior resection syndrome and systematic review of risk factors. Int J Surg. 2018;2018:234–41.CrossRef Croese A, Lonie J, Trollope A, Vangaveti VN, Ho YH. A meta-analysis of the prevalence of low anterior resection syndrome and systematic review of risk factors. Int J Surg. 2018;2018:234–41.CrossRef
24.
go back to reference Felt-Bersma RJF, Meuwissen SG. Anal manometry. Int J Color Dis. 1990;5:170–3.CrossRef Felt-Bersma RJF, Meuwissen SG. Anal manometry. Int J Color Dis. 1990;5:170–3.CrossRef
25.
go back to reference Carrington EV, Heinrich H, Knowles CH, et al. The international anorectal physiology working group (IAPWG) recommendations: standardized testing protocol and the London classification for disorders of anorectal function. Neurogastroenterol Motil. 2019;32:e13679.CrossRefPubMedPubMedCentral Carrington EV, Heinrich H, Knowles CH, et al. The international anorectal physiology working group (IAPWG) recommendations: standardized testing protocol and the London classification for disorders of anorectal function. Neurogastroenterol Motil. 2019;32:e13679.CrossRefPubMedPubMedCentral
26.
go back to reference Dulskas A, Samalavicius NE. Usefulness of anorectal manometry for diagnosing continence problems after a low anterior resection. Ann Coloproctol. 2016;32(3):101–4.CrossRefPubMedPubMedCentral Dulskas A, Samalavicius NE. Usefulness of anorectal manometry for diagnosing continence problems after a low anterior resection. Ann Coloproctol. 2016;32(3):101–4.CrossRefPubMedPubMedCentral
27.
go back to reference Ihnát P, Slívová I, Tulinsky L, Ihnát Rudinská L, Máca J, Penka I. Anorectal dysfunction after laparoscopic low anterior rectal resection for rectal cancer with and without radiotherapy (manometry study). J Surg Oncol. 2018;117:710–6.CrossRefPubMed Ihnát P, Slívová I, Tulinsky L, Ihnát Rudinská L, Máca J, Penka I. Anorectal dysfunction after laparoscopic low anterior rectal resection for rectal cancer with and without radiotherapy (manometry study). J Surg Oncol. 2018;117:710–6.CrossRefPubMed
28.
go back to reference Matzel KE, Bittorf B, Günther K, Stadelmaier U, Hohenberger W. Rectal resection with low anastomosis: functional outcome. Color Dis. 2003;5:458–64.CrossRef Matzel KE, Bittorf B, Günther K, Stadelmaier U, Hohenberger W. Rectal resection with low anastomosis: functional outcome. Color Dis. 2003;5:458–64.CrossRef
29.
go back to reference Bartlett L, Sloots K, Nowak M, Ho YH. Biofeedback therapy for symptoms of bowel dysfunction following surgery for colorectal cancer. Tech Coloproctol. 2011;15:319–26.CrossRefPubMed Bartlett L, Sloots K, Nowak M, Ho YH. Biofeedback therapy for symptoms of bowel dysfunction following surgery for colorectal cancer. Tech Coloproctol. 2011;15:319–26.CrossRefPubMed
30.
go back to reference Kim KH, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Effectiveness of biofeedback therapy in the treatment of anterior resection syndrome after rectal cancer surgery. Dis Colon Rectum. 2011;54(9):1107–13.CrossRefPubMed Kim KH, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Effectiveness of biofeedback therapy in the treatment of anterior resection syndrome after rectal cancer surgery. Dis Colon Rectum. 2011;54(9):1107–13.CrossRefPubMed
31.
go back to reference Liang Z, Ding W, Chen W, Wang Z, Du P, Cui L. Therapeutic evaluation of biofeedback therapy in the treatment of anterior resection syndrome after sphincter-saving surgery for rectal Cancer. Clin Colorectal Cancer. 2016;15:101–7.CrossRef Liang Z, Ding W, Chen W, Wang Z, Du P, Cui L. Therapeutic evaluation of biofeedback therapy in the treatment of anterior resection syndrome after sphincter-saving surgery for rectal Cancer. Clin Colorectal Cancer. 2016;15:101–7.CrossRef
32.
go back to reference Pucciani F, Ringressi MN, Redditi S, Masi A, Giani I. Rehabilitation of fecal incontinence after sphincter-saving surgery for rectal cancer: encouraging results. Dis Colon Rectum. 2008;51(10):1552.CrossRefPubMed Pucciani F, Ringressi MN, Redditi S, Masi A, Giani I. Rehabilitation of fecal incontinence after sphincter-saving surgery for rectal cancer: encouraging results. Dis Colon Rectum. 2008;51(10):1552.CrossRefPubMed
33.
go back to reference Mazor Y, Ejova A, Andrews A, Jones M, Kellow J, Malcolm A. Long-term outcome of anorectal biofeedback for treatment of fecal incontinence. Neurogastroenterol Motil. 2018;30:e13389.CrossRef Mazor Y, Ejova A, Andrews A, Jones M, Kellow J, Malcolm A. Long-term outcome of anorectal biofeedback for treatment of fecal incontinence. Neurogastroenterol Motil. 2018;30:e13389.CrossRef
Metadata
Title
Long term persistence and risk factors for anorectal symptoms following low anterior resection for rectal cancer
Authors
E. Koifman
M. Armoni
Y. Gorelik
A. Harbi
Y. Streltsin
S. D. Duek
R. Brun
Y. Mazor
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-03112-8

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.